Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that its subsidiary, Tepnel Pharma Services (Tepnel), has successfully achieved authorised customer service provider (CSP) status in the Ion Torrent Service Provider program on the Ion PGMTM (Personal Genome Machine) Sequencer. Ion Torrent’s CSP certification assures customers that the organization has been trained and tested to produce the highest quality sequence data in accordance with pre-prescribed standards and expectations.
The Ion PGM performs DNA sequencing by combining semiconductor technology and simple chemistry instead of using light as an intermediary signal. Tepnel Pharma Services will incorporate the Ion Torrent platform as part of its Molecular Genetic Services portfolio in support of biomarker discovery studies.
David Scott, Senior Director of Tepnel Pharma Services, said: ‘The certification of our next generation sequencing services using the Ion PGM Sequencer further demonstrates our commitment to offering customers the latest cutting-edge technologies and services to help them realise the requirements of their research needs. As a high-quality, regulatory-compliant service provider, we are pleased to gain another certification that validates our dedication to providing a service that is driven by the needs of today’s research in personalised medicines’.
About Hologic, Inc.:
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on breast health, diagnostics, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information on Hologic, please visit www.hologic.com
Hologic and associated logos are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.
About Tepnel Pharma Services:
Tepnel Pharma Services is the Contract Research Organization (CRO) group of Hologic. Tepnel specialises in the provision of pharmaceutical testing and molecular genetic services in support of drug development and companion diagnostics development. Tepnel’s pharmaceutical testing facilities are located in Manchester, England and Livingston, Scotland.
Forward-looking Statement Disclaimer:
This Media Release may contain forward-looking information that involves risks and uncertainties, including statements about Hologic, Inc. and our products and services. There can be no assurance these products and services will achieve the benefits described herein and that such benefits will be replicated in any particular manner with respect to an individual patient. Hologic disclaims any obligation to release publicly any updates or revisions to any such statements presented herein or to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based.
Marketing Communications Manager
Tel: + 44 (0) 161 946 2220